Cargando…
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
BACKGROUND: Lack of opportunity for radical surgery and postoperative tumor recurrence are challenges for surgeons and hepatocellular carcinoma (HCC) patients. This study aimed to develop nomograms to predict recurrence risk and recurrence-free survival (RFS) probability after conversion hepatectomy...
Autores principales: | Deng, Min, Zhao, Rongce, Guan, Renguo, Li, Shaohua, Zuo, Zhijun, Lin, Wenping, Wei, Wei, Guo, Rongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492285/ https://www.ncbi.nlm.nih.gov/pubmed/37689775 http://dx.doi.org/10.1186/s40001-023-01310-4 |
Ejemplares similares
-
Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study
por: Deng, Min, et al.
Publicado: (2023) -
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2022) -
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study
por: Deng, Min, et al.
Publicado: (2023) -
Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma
por: Guan, Renguo, et al.
Publicado: (2022) -
Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience
por: Zheng, Zehao, et al.
Publicado: (2022)